Get the Stockscreener App
177.86
1.06%
1.9092
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $177.86, with a volume of 606.47K.
It is up +1.06% in the last 24 hours and down -0.85% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$175.95
Open:
$175.78
24h Volume:
606.47K
Relative Volume:
0.68
Market Cap:
$19.88B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
21.27
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
-1.36%
1M Performance:
-0.85%
6M Performance:
-0.08%
1Y Performance:
+14.50%
1-Day Range:
$174.36
$177.97
1-Week Range:
$174.33
$180.63
52-Week Range:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
177.79 | 19.57B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
562.48 | 213.17B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
213.97 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.37 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.50 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
214.94 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Is Quest Diagnostics Incorporated (QDI) stock positioned for secular growthJuly 2025 Update & AI Driven Stock Reports - newser.com
Nicholas Company Inc. Sells 22,730 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
How supply chain issues affect Quest Diagnostics Incorporated stockEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Quest Diagnostics Incorporated stock trend forecast2025 Price Action Summary & Expert Curated Trade Ideas - newser.com
Published on: 2025-11-03 04:13:22 - newser.com
Can Quest Diagnostics Incorporated stock beat analyst consensusEarnings Overview Report & Capital Efficiency Focused Strategies - newser.com
Quest Diagnostics (DGX): Assessing Valuation After Recent Steady Share Price Performance - Yahoo Finance
Is Quest Diagnostics Incorporated stock cheap compared to fundamentals2025 Risk Factors & AI Enhanced Trade Execution Alerts - newser.com
Forecasting Quest Diagnostics Incorporated price range with options dataJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Why Analysts See the Story Changing for Quest Diagnostics Following New Tests and Upgraded Forecasts - Yahoo Finance
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Bessemer Group Inc. Has $519,000 Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Integrity Alliance LLC. Reduces Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Bought by Keybank National Association OH - MarketBeat
Why Quest Diagnostics Incorporated stock is favored by top institutionsOil Prices & Growth Focused Stock Reports - newser.com
Quest Diagnostics Incorporated stock outlook for YEAR2025 Stock Rankings & AI Enhanced Execution Alerts - newser.com
How Quest Diagnostics Incorporated stock performs in high volatility marketsBear Alert & Expert Curated Trade Setups - newser.com
Is Quest Diagnostics Incorporated stock in correction or buying zoneDay Trade & Breakout Confirmation Trade Signals - newser.com
Quest Diagnostics Incorporated $DGX Stock Holdings Increased by Envestnet Asset Management Inc. - MarketBeat
What technical signals suggest for Quest Diagnostics Incorporated stockWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
How Quest Diagnostics Incorporated (QDI) stock reacts to stronger dollarJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - newser.com
What Fibonacci levels say about Quest Diagnostics Incorporated reboundWeekly Trend Report & Technical Entry and Exit Tips - newser.com
Exit strategy if you’re trapped in Quest Diagnostics IncorporatedJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Can Quest Diagnostics Incorporated stock surprise with earnings upsideEarnings Summary Report & AI Driven Stock Movement Reports - newser.com
Will Quest Diagnostics Incorporated stock return to pre crisis levelsMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
Fjarde AP Fonden Fourth Swedish National Pension Fund Buys 11,000 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Ashton Thomas Private Wealth LLC Acquires 2,285 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
How currency fluctuations impact Quest Diagnostics Incorporated stockEntry Point & AI Driven Stock Reports - newser.com
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
J.P. Morgan Sticks to Their Hold Rating for Quest Diagnostics (DGX) - The Globe and Mail
Can Quest Diagnostics Incorporated (QDI) stock retain market dominanceTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Sumitomo Mitsui Trust Group Inc. Decreases Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Labcorp lifts annual profit forecast on strong diagnostic test demand - Reuters
Is Quest Diagnostics Incorporated stock supported by innovation pipelineMarket Activity Recap & Trade Opportunity Analysis - fcp.pa.gov.br
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):